CRISPR Therapeutics AG (CRSP)

56.90 +2.92 (+5.41%) USD  |  NASDAQ  |  Feb 24, 15:18
More

CRISPR Therapeutics Average Diluted Shares Outstanding (Quarterly)

Average Diluted Shares Outstanding (Quarterly) Chart

View Average Diluted Shares Outstanding (Quarterly) for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Average Diluted Shares Outstanding (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years

View Average Diluted Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Average Diluted Shares Outstanding (Quarterly) Benchmarks

View Average Diluted Shares Outstanding (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Novartis AG Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
EvoNext Holdings SA --